Faculty Bibliography

Rationale: Exposure to World Trade Center (WTC) dust and fumes is associated with onset of asthma-like respiratory symptoms in exposed community members including local workers, residents and clean-up workers. Although abnormal spirometry measurements are often not detected in these patients, impulse oscillometry (IOS) suggests abnormalities localized to the smaller airways. Peripheral C-reactive protein (CRP) is a marker of systemic inflammation. Since an association between CRP and asthma has been reported, we hypothesized that levels of CRP would be associated with lung function abnormalities as assessed by spirometry and IOS measurements in community members exposed to WTC dust/fumes and gasses. Methods: The WTC Environmental Health Center (EHC) is a treatment program for community members, with presumed WTC-related symptoms. Patients undergo a standardized evaluation including questionnaires and routine blood work, spirometry and IOS measurements. Between 10/1/2009 and 9/29/2011, a measurement of CRP was included for patients undergoing standardized visits. Measurements of lung function were compared utilizing the Wilcoxon test between subjects with normal vs. elevated CRP and further analyzed using linear regression models with log(CRP) as a continuous predictor. Regression analyses were adjusted for potential confounding factors including Body mass index (BMI), exposure category, and smoking history. Results: 208 WTC-exposed individuals met inclusion criteria. Valid spirometry and IOS data were available in 204 and 189 patients, respectively. Mean age was 49 years, 53% were female. Exposure categories (local workers, clean-up workers, residents) were associated with normal/elevated CRP levels (P=0.01). Smokers had a larger portion of elevated CRP (P=0.048). BMI was higher among the high CRP group (Wilcoxon test, P<0.001). FEV₁ and FVC were lower for the high CRP group (P=0.016, P=0.033). However, CRP level was not associated with the ratio FEV₁/FVC (P=0.58). The IOS measurements (R₅, R_5-20, AX ) were higher (P=0.01, P=0.003, P=.001, respectively) among the high CRP group. Multiple regression analysis confirmed that log(CRP) values were inversely correlated with % of predicted FEV 1 (P=0.009) and positively correlated with log(R₅) (P=0.02) and log(AX) (P=0.0045) after adjustment for log(BMI). Conclusions: Peripheral CRP was negatively correlated with levels of FEV₁ and positively correlated with IOS measurements in community members with WTC dust/gas/fume exposure. These data suggest a relationship between systemic inflammation, as reflected by CRP, and both large and small airway abnormalities in a WTC- exposed population

RATIONALE: Analysis of local in vivo inflammation is relevant to the understanding of pathogenesis and disease progression in emphysema. Bronchial reactivity is an early marker of disease in asthma but the relevance of reactivity to the natural history of emphysema is not understood. We hypothesize that bronchial reactivity is a phenotype of early emphysema that might be related to the degree of inflammation in the lung. METHODS: Normal subjects were enrolled as part of a normal volunteer protocol. Emphysema subjects were identified from the NYU Lung Cancer Biomarker Center CT-scan screening cohort. All patients underwent spirometry, plethysmography, diffusion, and oscillometry, as well as bronchoscopy with bronchoalveolar lavage (BAL). Bronchial reactivity was assessed by changes in FEV1, V50 and R5 . From the BAL fluid, cell count differential was obtained, as well as measurement of 39 cytokines in concentrated BAL fluid with Luminex using Human Cytokine Panel I (Millipore). Results amongst the groups were compared with ANOVA and post-hoc LSD comparison. RESULTS: Twenty patients were available for analysis: Six subjects in the control group, 6 emphysema subjects without bronchial reactivity (BR-), and 8 emphysema subjects with bronchial reactivity (BR+). Baseline demographics and pertinent spirometry/oscillometry are listed in Table 1. Emphysema subjects were all GOLD stage 0 or 1. Post-bronchodilator spirometric and oscillometric parameters were not significantly different between BR- and BR+ emphysema groups. There were 28/39 cytokines with reliably measurable levels. Both emphysema groups had elevated neutrophils and higher degree of inflammation as compared to controls (significant data shown Table 1). However, the BR+ emphysema group evidenced higher degree of neutrophils, IL-6, IL-8, G-CSF, Eotaxin, GRO and Fractalkine as compared with the BR- emphysema group. CONCLUSION: These data suggest that in early emphysema a phenotype of proximal and/or distal bronchial reactivity is associated with an increased degree of inflammation as assessed by neutrophils and in vivo inflammatory cytokines. In contrast with early asthma, the phenotype of bronchial reactivity in early emphysema may be characterized by neutrophilic inflammation produced by increased IL-8 in the lung. The role of IL-6, G-CSF, Eotaxin, GRO and Fractalkine in producing emphysema related bronchial reactivity requires further investigation. (Table Presented)

Rationale: The use of culture-independent techniques to evaluate resident microbial communities in the lung has opened opportunities to evaluate host response phenotype in health and disease. Background environmental microbiome found in saline and bronchoscope prior to bronchoscopy is characterized by high relative abundance of Propionibacterium. Our preliminary data from the lung microbiome project suggest that substitution of background environmental microbiome by Prevotella or Streptococcus microbiome is associated with higher inflammation. We hypothesize that patients with emphysema who have asymmetric disease on CT will have disappearance of background environmental microbiome in the more affected lung segments. We will also evaluate whether background environmental microbiome is associated with lower inflammation (neutrophil counts, and chemo-attractant cytokines). Methods: Subjects with emphysema were enrolled for research bronchoscopy from NYU/EDRN cohort and CT scans were classified as symmetrical or asymmetrical lung disease. Broncho-alveolar lavages (BAL) were obtained from the right and left lung. Sequencing of 300 bp 16S rDNA included V1-V2 region, performed with 454 pyrosequence. Propionibacterium was used as a marker of background environmental microbiome. Cytokines in BAL fluid will be assayed using Human Cytokine Panel I (Millipore). Results: To date, 15 subjects had sequence data from two segments of different lungs (5 normal volunteers, 6 symmetrical lung disease patients, and 4 asymmetrical lung disease patients). Healthy volunteers were younger than subjects with emphysema (41 +/- 11, 61 +/- 6 respectively, p = 0.003). Although no significant difference in FEV1 was observed, emphysema groups trended to have lower FEV1/FVC (p=ns). There were no differences in high relative abundant taxa (greater than 0.05) between the right and left lung of normal volunteers and emphysema subjects with symmetrical lung disease. However, despite the small n, emphysema subjects with asymmetrical lung disease trended to have higher relative abundance of background environmental microbiome in lung segments with less disease ( Propionibacterium relative abundance = 0.13 +/- 0.04 for segments with less disease as compared with 0.03 +/- 0.04 in the more disease segments, p < 0.08). We will complete sequence in 5 more emphysema subjects and compare microbiota with in-vivo BAL cytokines. Conclusions: Patients with observable asymmetrical lung disease have lower background environmental microbiome in more diseased lung when compared to the less diseased side. This difference was not observed in normal volunteers and patients with symmetrical lung disease. Disappearance of background environmental microbiome in more diseased lung segments suggests higher airway colonization, which might be associated with subclinical inflammation

INTRODUCTION: We have previously shown improvement in spirometry parameters in symptomatic WTC dust exposed community members enrolled in the WTC Environmental Health Center treatment program. Additionally, impulse oscillometry (IOS) has demonstrated evidence for distal lung injury not apparent on spirometry. We hypothesize that longitudinal change of spirometry will differ based on presence or absence of distal airway injury and its response to bronchodilator at baseline. METHODS: 810 patients were identified with more than one spirometry and IOS assessment. IOS parameters included resistance at 5 and 20Hz (R₅ and R₂₀) and frequency dependence of resistance assessed as the difference between these parameters (R_5-20). Linear mixed effects modeling evaluated longitudinal changes in IOS parameters, FVC and FEV₁ for the entire population. Separate models were fit for subgroups categorized based on normal vs. abnormal baseline spirometry and normal vs. abnormal baseline IOS (R₅>3.96 cmH2O/L/s). Analyses were adjusted for confounding factors (age, gender, BMI, race/ethnicity, smoking, exposure category and dust cloud exposure). RESULTS: Mean age was 50yr. Patients were mostly female (52%) and had diverse race/ethnicity. At baseline, mean FVC was 91+/-17% predicted and FEV₁ was 88+/-18% predicted. A normal spirometry pattern was noted in the majority (67%; n=542). Despite normal spirometry, IOS revealed abnormalities in 67% (n=364). Longitudinal analysis of IOS parameters (R₅, R₂₀, R_5-20) over time revealed no significant trends for the entire population and for subgroups categorized by baseline spirometry pattern. In contrast, the longitudinal change in spirometry variables differed based on presence of IOS abnormality. In patients with normal spirometry, FEV₁ increased more rapidly in patients with abnormal baseline IOS compared to those with normal IOS (0.76 vs. 0.52 % predicted/yr; Table 1). For patients with abnormal baseline spirometry, FVC increased more rapidly in the abnormal vs. normal IOS patients (1.73 vs. 1.02 % predicted/yr). Patients with IOS response to bronchodilator (highest quartile for improvement of R₅ post bronchodilator) demonstrated a more rapid longitudinal increase in FEV₁ compared with patients without bronchodilator response (lowest quartile)(0.88 vs. 0.53 % predicted/yr,; Table 2). CONCLUSIONS: Spirometry parameters demonstrated improvement over time, while improvement in IOS parameters was not evident, suggesting potential irreversible injury in the distal lung. However, assessment of baseline distal airway function and its acute response to bronchodilator predicted longitudinal response of spirometry in patients enrolled in a treatment program. (Table Presented)

OBJECTIVE: : The course of lung function in community members exposed to World Trade Center (WTC) dust and fumes remains undefined. We studied longitudinal spirometry among patients in the WTC Environmental Health Center (WTCEHC) treatment program. METHODS: : Observational study of 946 WTCEHC patients with repeated spirometry measures analyzed on the population as a whole and stratified by smoking status, initial spirometry pattern, and WTC-related exposure category. RESULTS: : Improvement in forced vital capacity (54.4 mL/yr; 95% confidence interval, 45.0 to 63.8) and forced expiratory volume in 1 second (36.8 mL/yr; 95% confidence interval, 29.3 to 44.3) was noted for the population as a whole. Heavy smokers did not improve. Spirometry changes differed depending on initial spirometry pattern and exposure category. CONCLUSION: : These data demonstrate spirometry improvement in select populations suggesting reversibility in airway injury and reinforcing the importance of continued treatment.

BACKGROUND: Obesity is frequently associated with respiratory symptoms despite normal large airway function as assessed by spirometry. However, reduced functional residual capacity and expiratory reserve volume are common and might reflect distal airway dysfunction. Impulse oscillometry (IOS) might identify distal airway abnormalities not detected using routine spirometry screening. Our objective was to test the hypothesis that excess body weight will result in distal airway dysfunction detected by IOS that reverses after bariatric surgery. The setting was a university hospital. METHODS: A total of 342 subjects underwent spirometry, plethysmography, and IOS before bariatric surgery. Of these patients, 75 repeated the testing after the loss of 20% of the total body weight. The data from 47 subjects with normal baseline spirometry and complete pre- and postoperative data were analyzed. RESULTS: IOS detected preoperative distal airway dysfunction despite normal spirometry findings by an abnormal airway resistance at an oscillation frequency of 20 Hz (4.75 +/- 1.2 cm H(2)O/L/s), frequency dependence of resistance from 5 to 20 Hz (2.20 +/- 1.6 cm H(2)O/L/s), and reactance at 5 Hz (-3.47 +/- 2.1 cm H(2)O/L/s). Postoperatively, the subjects demonstrated 57% +/- 15% excess weight loss. The body mass index decreased (from 44 +/- 6 to 32 +/- 5 kg/m(2), P < .001). Improvements in functional residual capacity (from 59% +/- 11% to 75% +/- 20% predicted, P < .001) and expiratory reserve volume (from 41% +/- 20% to 75% +/- 20% predicted, P < .001) were demonstrated. Distal airway function also improved: airway resistance at an oscillation frequency of 20 Hz (3.91 +/- .9, P < .001), frequency dependence of resistance from 5 to 20 Hz (1.17 +/- .9, P < .001), and reactance at 5 Hz (-1.85 +/- .9, P < .001). CONCLUSION: The present study detected significant distal airway dysfunction despite normal preoperative spirometry findings. The effect of increased body weight was likely the main mechanism for these abnormalities. However, the inflammatory state of obesity or associated respiratory disease could also be invoked. These abnormalities improved significantly toward normal after weight loss. The results of the present study highlight the importance of bariatric surgery as an effective intervention in reversing these respiratory abnormalities.

Objectives. We assessed associations between new-onset (post-September 11, 2001 [9/11]) lower respiratory symptoms reported on 2 surveys, administered 3 years apart, and acute and chronic 9/11-related exposures among New York City World Trade Center-area residents and workers enrolled in the World Trade Center Health Registry. Methods. World Trade Center-area residents and workers were categorized as case participants or control participants on the basis of lower respiratory symptoms reported in surveys administered 2 to 3 and 5 to 6 years after 9/11. We created composite exposure scales after principal components analyses of detailed exposure histories obtained during face-to-face interviews. We used multivariate logistic regression models to determine associations between lower respiratory symptoms and composite exposure scales. Results. Both acute and chronic exposures to the events of 9/11 were independently associated, often in a dose-dependent manner, with lower respiratory symptoms among individuals who lived and worked in the area of the World Trade Center. Conclusions. Study findings argue for detailed assessments of exposure during and after events in the future from which potentially toxic materials may be released and for rapid interventions to minimize exposures and screen for potential adverse health effects.

Introduction: Pompe disease is a rare, autosomal recessive disorder caused by deficiency of the glycogen-degrading lysosomal enzyme acid alpha-glucosidase. Late-onset Pompe disease is a multisystem condition, with a heterogeneous clinical presentation that mimics other neuromuscular disorders. Methods: Objective is to propose consensus-based treatment and management recommendations for late-onset Pompe disease. Methods: A systematic review of the literature by a panel of specialists with expertise in Pompe disease was undertaken. Conclusions: A multidisciplinary team should be involved to properly treat the pulmonary, neuromuscular, orthopedic, and gastrointestinal elements of late-onset Pompe disease. Presymptomatic patients with subtle objective signs of Pompe disease (and patients symptomatic at diagnosis) should begin treatment with enzyme replacement therapy (ERT) immediately; presymptomatic patients without symptoms or signs should be observed without use of ERT. After 1 year of ERT, patients' condition should be reevaluated to determine whether ERT should be continued. Muscle Nerve, 2012.